| Product Code: ETC7212318 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 France Antimicrobial Resistance Market Overview |
3.1 France Country Macro Economic Indicators |
3.2 France Antimicrobial Resistance Market Revenues & Volume, 2021 & 2031F |
3.3 France Antimicrobial Resistance Market - Industry Life Cycle |
3.4 France Antimicrobial Resistance Market - Porter's Five Forces |
3.5 France Antimicrobial Resistance Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.6 France Antimicrobial Resistance Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.7 France Antimicrobial Resistance Market Revenues & Volume Share, By Mechanism of Action, 2021 & 2031F |
3.8 France Antimicrobial Resistance Market Revenues & Volume Share, By Pathogen, 2021 & 2031F |
4 France Antimicrobial Resistance Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of bacterial infections in France |
4.2.2 Growing awareness about the importance of combating antimicrobial resistance |
4.2.3 Technological advancements in the development of new antimicrobial agents |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for the approval of antimicrobial drugs |
4.3.2 Rising healthcare costs associated with the treatment of resistant infections |
4.3.3 Lack of new antibiotics in the pipeline for drug development |
5 France Antimicrobial Resistance Market Trends |
6 France Antimicrobial Resistance Market, By Types |
6.1 France Antimicrobial Resistance Market, By Indication |
6.1.1 Overview and Analysis |
6.1.2 France Antimicrobial Resistance Market Revenues & Volume, By Indication, 2021- 2031F |
6.1.3 France Antimicrobial Resistance Market Revenues & Volume, By Complicated Urinary Tract Infections (cUTI), 2021- 2031F |
6.1.4 France Antimicrobial Resistance Market Revenues & Volume, By Blood stream infections, 2021- 2031F |
6.1.5 France Antimicrobial Resistance Market Revenues & Volume, By Acute bacterial skin and skin structure infections (ABSSSI), 2021- 2031F |
6.1.6 France Antimicrobial Resistance Market Revenues & Volume, By Hospital acquired bacterial pneumonia and ventilator acquired bacterial pneumonia (HABP and VABP), 2021- 2031F |
6.1.7 France Antimicrobial Resistance Market Revenues & Volume, By Community acquired pneumonia (CAP), 2021- 2031F |
6.1.8 France Antimicrobial Resistance Market Revenues & Volume, By Others, 2021- 2031F |
6.2 France Antimicrobial Resistance Market, By Drug Class |
6.2.1 Overview and Analysis |
6.2.2 France Antimicrobial Resistance Market Revenues & Volume, By Combination therapies, 2021- 2031F |
6.2.3 France Antimicrobial Resistance Market Revenues & Volume, By Tetracyclines, 2021- 2031F |
6.2.4 France Antimicrobial Resistance Market Revenues & Volume, By Cephalosporins, 2021- 2031F |
6.2.5 France Antimicrobial Resistance Market Revenues & Volume, By Glycopeptides and Lipoglycopeptides, 2021- 2031F |
6.2.6 France Antimicrobial Resistance Market Revenues & Volume, By Oxazolidinones, 2021- 2031F |
6.2.7 France Antimicrobial Resistance Market Revenues & Volume, By Others, 2021- 2031F |
6.3 France Antimicrobial Resistance Market, By Mechanism of Action |
6.3.1 Overview and Analysis |
6.3.2 France Antimicrobial Resistance Market Revenues & Volume, By Protein Synthesis Inhibitors, 2021- 2031F |
6.3.3 France Antimicrobial Resistance Market Revenues & Volume, By Cell Wall Synthesis Inhibitors, 2021- 2031F |
6.3.4 France Antimicrobial Resistance Market Revenues & Volume, By Others, 2021- 2031F |
6.4 France Antimicrobial Resistance Market, By Pathogen |
6.4.1 Overview and Analysis |
6.4.2 France Antimicrobial Resistance Market Revenues & Volume, By Klebsiella pneumoniae, 2021- 2031F |
6.4.3 France Antimicrobial Resistance Market Revenues & Volume, By Pseudomonas aeruginosa, 2021- 2031F |
6.4.4 France Antimicrobial Resistance Market Revenues & Volume, By Staphylococcus aureus, 2021- 2031F |
6.4.5 France Antimicrobial Resistance Market Revenues & Volume, By Enterococcus Spp, 2021- 2031F |
6.4.6 France Antimicrobial Resistance Market Revenues & Volume, By Escherichia coli, 2021- 2031F |
6.4.7 France Antimicrobial Resistance Market Revenues & Volume, By Others, 2021- 2031F |
7 France Antimicrobial Resistance Market Import-Export Trade Statistics |
7.1 France Antimicrobial Resistance Market Export to Major Countries |
7.2 France Antimicrobial Resistance Market Imports from Major Countries |
8 France Antimicrobial Resistance Market Key Performance Indicators |
8.1 Percentage increase in public health campaigns focused on antimicrobial resistance awareness |
8.2 Number of research and development partnerships for antimicrobial drug discovery |
8.3 Rate of adoption of antimicrobial stewardship programs in healthcare facilities |
9 France Antimicrobial Resistance Market - Opportunity Assessment |
9.1 France Antimicrobial Resistance Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.2 France Antimicrobial Resistance Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.3 France Antimicrobial Resistance Market Opportunity Assessment, By Mechanism of Action, 2021 & 2031F |
9.4 France Antimicrobial Resistance Market Opportunity Assessment, By Pathogen, 2021 & 2031F |
10 France Antimicrobial Resistance Market - Competitive Landscape |
10.1 France Antimicrobial Resistance Market Revenue Share, By Companies, 2024 |
10.2 France Antimicrobial Resistance Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here